Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Wednesday, November 09, 2005
Serono - the odds are shortening
Who will buy Serono? The odds are shortening on Novartis and GSK. They are lengthening on Pfizer and Sanofi Aventis ( too many antitrust issues).
No comments:
Post a Comment